Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Janson

Showing results (61-70 of 132) with videos related to

Pageof 14
Sort By:
Blood|February 25, 1999
The somatostatin analog octreotide inhibits growth of interleukin-6 (IL-6)-dependent and IL-6-independent human multiple myeloma cell linesP Georgii-Hemming, T Strömberg, E T Janson, et al.
Medical Oncology (Northwood, London, England)|May 25, 2002
Treatment of malignant endocrine pancreatic tumors with a combination of alpha-interferon and somatostatin analogsM L Fjällskog, A Sundin, J E Westlin, et al.
Cancer Research|December 1, 1995
Somatostatin receptor scintigraphy in patients with carcinoid tumors: comparison between radioligand uptake and tumor markersK M Kälkner, E T Janson, S Nilsson, et al.
Pediatric Pulmonology|March 14, 2009
Phrenic nerve palsy in children associated with confirmed intrathoracic tuberculosis: diagnosis and clinical courseP Goussard, R P Gie, S Kling, et al.
World Journal of Gastroenterology|December 31, 2015
Histidine decarboxylase and urinary methylimidazoleacetic acid in gastric neuroendocrine cells and tumoursApostolos V Tsolakis, Lars Grimelius, Göran Granerus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1997
Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral centerE T Janson, L Holmberg, M Stridsberg, et al.
Medical Oncology (Northwood, London, England)|October 1, 2004
Subtype selective interactions of somatostatin and somatostatin analogs with sst1, sst2, and sst5 in BON-1 cellsEva Ludvigsen, Mats Stridsberg, John E Taylor, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1997
Induction of apoptosis in neuroendocrine tumors of the digestive system during treatment with somatostatin analogsH Imam, B Eriksson, A Lukinius, et al.
Expert Review of Respiratory Medicine|January 29, 2021
Pediatric bronchoscopy: recent advances and clinical challengesP Goussard, P Pohunek, E Eber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
Expression of molecular targets for tyrosine kinase receptor antagonists in malignant endocrine pancreatic tumorsMarie-Louise H Fjällskog, Margareta H Lejonklou, Kjell E Oberg, et al.
Pageof 14

Showing results (61-70 of 132) with videos related to

Sort By:
Pageof 14
Blood|February 25, 1999
The somatostatin analog octreotide inhibits growth of interleukin-6 (IL-6)-dependent and IL-6-independent human multiple myeloma cell linesP Georgii-Hemming, T Strömberg, E T Janson, et al.
Medical Oncology (Northwood, London, England)|May 25, 2002
Treatment of malignant endocrine pancreatic tumors with a combination of alpha-interferon and somatostatin analogsM L Fjällskog, A Sundin, J E Westlin, et al.
Cancer Research|December 1, 1995
Somatostatin receptor scintigraphy in patients with carcinoid tumors: comparison between radioligand uptake and tumor markersK M Kälkner, E T Janson, S Nilsson, et al.
Pediatric Pulmonology|March 14, 2009
Phrenic nerve palsy in children associated with confirmed intrathoracic tuberculosis: diagnosis and clinical courseP Goussard, R P Gie, S Kling, et al.
World Journal of Gastroenterology|December 31, 2015
Histidine decarboxylase and urinary methylimidazoleacetic acid in gastric neuroendocrine cells and tumoursApostolos V Tsolakis, Lars Grimelius, Göran Granerus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1997
Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral centerE T Janson, L Holmberg, M Stridsberg, et al.
Medical Oncology (Northwood, London, England)|October 1, 2004
Subtype selective interactions of somatostatin and somatostatin analogs with sst1, sst2, and sst5 in BON-1 cellsEva Ludvigsen, Mats Stridsberg, John E Taylor, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1997
Induction of apoptosis in neuroendocrine tumors of the digestive system during treatment with somatostatin analogsH Imam, B Eriksson, A Lukinius, et al.
Expert Review of Respiratory Medicine|January 29, 2021
Pediatric bronchoscopy: recent advances and clinical challengesP Goussard, P Pohunek, E Eber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
Expression of molecular targets for tyrosine kinase receptor antagonists in malignant endocrine pancreatic tumorsMarie-Louise H Fjällskog, Margareta H Lejonklou, Kjell E Oberg, et al.
Pageof 14